KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.

Summary

This study is a multicenter, randomized, double-Blind Phase III Study to compare the clinical efficacy and safety of KN046 plus gemcitabine and nab-paclitaxel versus placebo plus gemcitabine and nab-paclitaxel in subjects with advanced pancreatic ductal adenocarcinoma who have not previously received systemic treatment.

Timeline

Start

2022-01-20

Primary completion

2024-04-30

Completion

2024-08-30

Drugs

Indications